ASPM overexpression has been observed in various cancers (Xu et al., 2019, 2020; Zhou et al., 2020; Alsiary et al., 2014; Bruning-Richardson et al., 2011; Saleh et al., 2020; Xie et al., 2017; Tian and Wang, 2020; Timaner and Shaked, 2020; Hsu et al., 2019; Wang et al., 2013; Tang et al., 2019; Lin et al., 2008; Yuan et al., 2020; Wu et al., 2021) and thus might serve as a prognostic marker in various contexts. This evidence concerns the gene ASPM and cancer.